Cerestar launch new slow release sugar
Isomaltulose has very low glycemic and insulin response, is non-cariogenic and well tolerated by the gastrointestinal tract. The glycemic and insulinemic profiles in pre-diabetic subjects are similar to those observed after intake of fructose.
17/06/05 Cerestar Food & Pharma Specialties Europe has unveiled C*VitalStar, a unique, slow release sugar, which can reduce both the glycaemic and insulinemic response in foods and promote sustained energy release. This exclusive new product is derived from isomaltulose, which occurs naturally in honey and cane juice. The company says their product is the first slow release sugar to deliver both glucose and fructose, as sucrose does, but results in a very low blood insulin response.
Isomaltulose has very low glycemic and insulin response, is non-cariogenic and well tolerated by the gastrointestinal tract. The glycemic and insulinemic profiles in pre-diabetic subjects are similar to those observed after intake of fructose. This positions isomaltulose as a beneficial carbohydrate for overweight pre-diabetic individuals.
C*VitalStar has preliminary applications as a single ingredient in soft, isotonic and sports drinks, meal replacement beverages, energy and nutritional bars, breakfast cereals and biscuits. It is likely that its application will also extend to confectionery, bakery and sweets.
“Our customers are increasingly demanding premium ingredients that meet their criteria in terms of health but without sacrificing on taste. We feel C*VitalStar strikes this balance and fulfils this need with a revolutionary, naturally derived product”, says Mark Wastijn, Marketing Director of Cerestar Food & Pharma Specialties Europe.
Whilst its primary use will be as a single ingredient, C*VitalStar can also work equally well in combination with other ingredients, to solve specific application needs.
Extensive research has proven that foods with low GI and carbohydrate scores keep blood sugars stable, eliminating the peaks and troughs, which can lead to snacking between meals and over-eating.
A recent report by the World Health Organisation calls for an immediate reduction in the overall consumption of sugars and other rapidly absorbable carbohydrates, along with increased daily physical activity, to stem the tide of obesity and type 2 diabetes, being experienced across the developed world.
In the UK alone, commonly accepted research says that one in four UK adults will be 30lbs over-weight by 2010, while around three million people are now said to be following a low carbohydrate regime.
Cerestar Food & Pharma Specialties Europe’s C*VitalStar is approved for use in the EU in all foods according to GMP. In the USA, isomaltulose has GRAS (Generally Recognised As Safe) status.
Earlier this year Palatinit launched their isomaltulose product palatinose.
www.cerestarfoodandpharma.com
